Scaling Single-Cell Genomics with Seqera to Deliver Clinical Impact at Industry-Leading Costs
Read the full case study70%
reduction in pipeline costs over 2 years
1000s
samples per day processed on the same compute
Dozens
customers supported simultaenously
Aim
Enhance understanding of gene-disease relationships, accelerate the path from data to insights at industry-leading costs, and drive faster drug discovery through increased sample throughput.Challenges
- →Processing multi-omics data from 1000s of cells is time-consuming, resource-demanding and costly.
- →Biological data is becoming increasingly more complex making it difficult to make correlations.
- →Existing tools require manual associative or correlative testing, which cannot handle complex data types.
— Victor Weigman, VP Computational Biology & Analytics
Solution
Nextflow
Powering BaseJumper bioinformatics platform for internal and external customers.
MultiQC
Enabling quality control, metadata reporting and visualization of results.
Seqera
Optimization of speed, reliability, and cost efficiency of custom developed pipelines.
Results
- →Processing 1000s of samples/day on the same compute.
- →70% reduction in pipeline costs over 2 years.
- →Support dozens of customer requests simultaneously.
70%
Opportunity
Increased sample throughput
Process a higher volume of samples per day using the same compute, enabling faster data access for customers.
Reduced pipeline costs
Lower the cost of pipeline execution and number of resubmissions, allowing customers to benefit from more affordable data processing.
Improved scalability
Support multiple requests simultaneously, allowing for more customer requests to be processed more quickly.
About
BioSkryb Genomics is ushering in the next generation of single-cell technology with industry-first multiomic products, custom services, and cutting-edge computational biology. BioSkryb Genomics enable the most complete multiomic view of the cellular ecosystem, including integration of whole genome and full-length whole transcriptome sequencing data from each cell.
BioSkryb’s ResolveDNA and ResolveOME single cell product portfolio is empowering the transformation of cellular discovery and disease research through highfidelity analyses of individual cells. Computational analysis is enabled by our cloud-based informatics platform, BaseJumper. ResolveServices is our custom service group, leveraging our single-cell multiomics experts in the execution of customer projects designed to customer specification. Our products and services are broadly used in oncology, cell and gene therapy, neurology research, and in the preimplantation genetic testing (PGT) field.
To learn more, visit https://www.bioskryb.com/